New tool aims to better measure breathlessness in lung patients
NCT ID NCT02229994
First seen Nov 20, 2025 · Last updated Jun 08, 2026 · Updated 23 times
Summary
This study tested a new self-administered questionnaire designed to measure shortness of breath and its impact on daily life in people with chronic respiratory diseases like COPD, pulmonary fibrosis, and cystic fibrosis. Researchers enrolled 199 adults to check if the tool is reliable and useful in clinical practice. The goal was to improve how doctors assess breathlessness, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (WITH - WITHOUT REHABILITATION) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Service de Pneumologie AP-HP, Hôpitaux Universitaires Paris Centre
Paris, 75006, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.